America can either cede the future of biotechnology to our adversaries or summon the vision and resolve to lead it.

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the TD Cowen ...

Forbion BioEconomy Fund I reaches hard cap, following its first close in 2024.The Fund's planetary health mandate leverages ...

The Nation has won overall best at the Ninth Open Forum on Agricultural Biotechnology (OFAB) Nigeria Media Awards. The ...

Nautilus Biotechnolgy ( ($NAUT) ) has shared an announcement. On November 3, 2025, Nautilus Biotechnology, Inc. announced that it has regained ...

Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

Corden BioChem, an expert in industrial biotechnology, could resume production at the bioethanol factory it took over from Swiss Clariant in southern Romania (or "Lesser Wallachia" as indicated by the ...

iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to a broad basket of industry-leading biotech equities. The fund's strategy ...

Viagen Pets and Equine is a biotechnology company that will produce genetic twins of customers' pets and livestock. But its conservation efforts are what attracted Colossal.

Amgen Inc. raised its full-year guidance after third-quarter results beat expectations, a positive sign in light of hurdles ...